China Pharmaceuticals and Healthcare Report Q1 2015

Business Monitor International
December 17, 2014
204 Pages - SKU: BMI5416301
Countries covered: China

China Pharmaceuticals and Healthcare Report Q1 2015

BMI View: Improvements in intellectual property protection, an ageing population and increasing accessto healthcare will drive the robust growth of China's pharmaceutical market. This will attract foreign drugmanufacturers despite the downside risks of pharmaeconomics and the government's crackdown on illegalpractices.

Headline Expenditure Projections

Pharmaceuticals: CNY532.4bn (USD86.6bn) in 2013 to CNY616.1bn (USD100.6bn) in 2014; +15.7%in local currency and +16.1% in US dollar terms.

Healthcare: CNY3,230.8bn (USD525.4bn) in 2013 to CNY3,733.1bn (USD609.2bn) in 2014; +15.6% inlocal currency terms and +15.9% in US dollar terms. Forecast has been upgraded from Q414 due toupgraded growth in private health expenditure.



More Prescription Drugs reports by Business Monitor International

Namibia Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Namibia Pharmaceuticals and Healthcare Report Q1 2015BMI View: Recent comments by the public relations officer of the Ministry of Health and Social Services,Ester Paulus, that ...
Moldova Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Moldova Pharmaceuticals and Healthcare Report Q1 2015BMI View: The Moldovan pharmaceutical market presents limited opportunities for investors in the shortterm, but with the country opening ...
Ghana Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Ghana Pharmaceuticals and Healthcare Report Q1 2015BMI View: We anticipate that the continuing roll-out of biometric registration and expansion of thecommunity-based health planning and services ...
Central America Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Central America Pharmaceuticals and Healthcare Report Q1 2015BMI View: Central America will continue to offer revenue-generating opportunities for multinationalpharmaceutical companies. An ageing population, favourable tax ...
See all reports like this >>

More China Prescription Drugs reports

Pharmaceuticals Markets in China by Asia Market Information & Development Company
Pharmaceuticals Markets in ChinaChina's demand for Pharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production ...
Osteoporosis Drugs Markets in China by Asia Market Information & Development Company
Osteoporosis Drugs Markets in ChinaChina's demand for Osteoporosis Drugs has grown at a fast pace in the past decade. In the next decade, both production ...
Mental Illness Drugs Markets in China by Asia Market Information & Development Company
Mental Illness Drugs Markets in ChinaChina's demand for Mental Illness Drugs has grown at a fast pace in the past decade. In the next decade, ...
Hypertension Drugs Markets in China by Asia Market Information & Development Company
Hypertension Drugs Markets in ChinaChina's demand for Hypertension Drugs has grown at a fast pace in the past decade. In the next decade, both production ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!